Alteration of Homograft Reaction by A-methopterin in Lethally Irradiated Mice Treated with Homologous Marrow
- 1 December 1958
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 99 (3), 651-653
- https://doi.org/10.3181/00379727-99-24450
Abstract
Mice which would normally succumb to a homograft reaction following an LD98 exposure to X-irradiation and homologous marrow inoculation, may be spared if they are treated with the folic acid antagonist, A-methopterin. Using different treatment schedules, varying degrees of effectiveness from increased survival following a typical reaction, to no detectable reaction, may be obtained. Weight curves demonstrate the suppression of this reaction in hybrid male mice exposed to 800 r X-irradiation, inoculated with parental-strain marrow and treated every 48 hours with A-methopterin for 9 treatments at a dose of 1.5 mg/kg body weight Similar results were observed for female mice given A-methopterin at a dose of 3 mg/ kg body weight every 48 hours for 5 treatments. The relationship between drug toxicity and effectiveness in altering the homograft reaction is discussed.Keywords
This publication has 6 references indexed in Scilit:
- Effect of 6-Mercaptopurine on Antibody Production.Experimental Biology and Medicine, 1958
- Immunological Characteristics of Radiation ChimaerasJNCI Journal of the National Cancer Institute, 1958
- Relative Effects of Splenic and Bone-Marrow Cells on Lethally Irradiated MiceJNCI Journal of the National Cancer Institute, 1958
- Preclusion of Secondary Phase of Irradiation Syndrome by Inoculation of Fetal Hematopoietic Tissue Following Lethal Total-Body X IrradiationJNCI Journal of the National Cancer Institute, 1958
- HOMOLOGOUS BONE MARROW IN THE TREATMENT OF RADIATION INJURY IN MICE1957
- Studies on the mechanism of action of chemotherapeutic agents in cancer. I.A sex difference in toxicity to the folic acid analogue, 4-amino-pteroylglutamic acidCancer, 1950